Dr. Abdullah Al-Salloum, finance professor at Imam Muhammad bin Saud Islamic University, confirmed that Jomjoom Pharma ranks first in financial performance among pharmaceutical companies listed on the market, pointing to its dominance in terms of market share and sales volume.

This assessment comes amid the competitiveness of the Saudi pharmaceutical sector, which is witnessing continuous development and growth in the number of listed companies.

Al-Salloum stated, during television remarks on Al-Akhbariya channel, that Jomjoom Pharma has a strong financial position, emphasizing it is debt-free, which supports its financial strength compared to its competitors in the sector.

On the other hand, Al-Salloum pointed out that Al-Dawaa Company, despite its long history in the market, achieves the lowest profit margins among listed companies, and its financial results are characterized by greater volatility.

Al-Salloum's remarks came in response to a question about the best company in terms of financial performance among all pharmaceutical companies listed on the market.

Display the tweet on platform X

Observers believe that the distinguished financial performance of Jomjoom Pharma reflects the success of its strategy in dominating the market. In contrast, Al-Dawaa faces challenges related to profit margins despite its long history. These performance differences may affect investor trends within the sector.